Table 1.
Demographic and clinical characteristics of the subjects
| Variable | category | |
|---|---|---|
| Age (years) | 37.44±15.59 (18-84) | |
| Gender | Female | 113 (64.2) |
| Male | 63 (35.8) | |
| Co-Morbidity | Diabetes Mellitus | 54 (30.68) |
| Hypertension | 42 (23.9) | |
| Ischemic heart disease | 15 (8.52) | |
| Liver Function Test (LFT) | ALT (IU/L) | 130.09±179.03 (15-1600) |
| AST (IU/L) | 99.89±152.45 (15-1436) | |
| AlkP | 408.37±230.77 (149-1660) | |
| Billirubin (total) (mg/dL) | 1.85±2.74 (0.50 - 18.50) | |
| Billirubin (direct) (mg/dL) | 0.80±1.78 (0.06 - 10.20) | |
| Viral marker | HCVab (positive) | 5 (2.84) |
| HBsAg (positive) | 34 (19.32) | |
| HIVab (positive) | 6 (3.40) | |
| serology | ANA (positive) | 34 (19.32) |
| Ceruloplasmin | Positive: 3 (1.70) | |
| Decreased: 11 (6.25) | ||
| Span (Positive) | 42 (23.86) | |
| Fatty Liver | No | 60 (34.10) |
| Grade 1 | 39 (22.16) | |
| Grade 2 | 44 (25.00) | |
| Grade 3 | 33 (18.75) |